X

The New PeerReviewTM Module of the PathData® System Greatly Reduces Time Needed to Complete Preclinical Studies

PDS Pathology Data Systems Ltd. has introduced a peer review program as the latest innovation to the PathData® System, an industry leading preclinical software tool. PeerReviewTM, the newest PathData® System module, is fully integrated and allows for the efficient and very flexible peer reviewing of preclinical safety studies, slashing the time to complete peer reviews by up to 75%.

Scotrun, PA (PRWeb) November 17, 2006 -- Innovative preclinical software vendor PDS Pathology Data Systems Ltd., recently announced the release of its novel PeerReviewTM module that allows for a most efficient formal cross-check of preclinical histopathology data and the option of easily integrating and recording the pertaining results via the system's pathology report generating tool.

Dr. Hannes Westen, lead designer of the software, provided the key design concepts that make this a truly unique, and very powerful scientific tool. "The peer-review process has always been one of the last steps of a professional preclinical study that seems to bring progress to a halt. Our goal was to combine the intuitive design of the PathData® System with the needs of our users in order to make an otherwise laborious and time-consuming process into a simple, straightforward and integrated step in their workflow, which has resulted in a time savings of up to 75%", said Dr. Westen. "The idea of the new PeerReviewTM program, therefore, was to put the full power and flexibility of the PathData® System to work in building a fast and flexible tissue selection mode for automatic record-keeping of all possible differences between the original and the peer reviewer's data, and for an optional integration of the consensus data. The program allows for a full range of flexible options for selecting what portion(s) of a study will be peer reviewed with optional inclusion of the results into a formal pathology report via our standard pathology report managing system." He went on to say, "We certainly have designed our PeerReviewTM module with the same flexibility and scientific functionality as the rest of our systems and, by all the feedback we have received thus far, we have again far exceeded the expectations of our user community."

The PathData® System is the recognized gold standard for preclinical pathology, offering users a complete array of postmortem functionalities - from necropsy and tissue preparation to microscopic evaluation, statistics, table generation, peer review, and FDA-compliant final report generation.

The antemortem aspects of preclinical studies are covered by the company's ToxData® System for toxicology and clinical pathology as well as by the ReproData® System for reproductive toxicology and teratology. All three systems are tightly integrated and form the foundation of the PDS Preclinical Suite of products. The systems are modular and scalable to grow with the users, so they are an excellent option for the entire range of customers -- from single users to global, multi-site organizations. Seven of the top ten pharmaceutical companies use PDS products.

The same powerful software is available to users of any size via the PDS Hosted Subscription Option, which allows users to access the software from the PDS hosting center on a pay-as-you-go basis with no capital expense.
PDS Pathology Data Systems will be attending the ACVP Meeting in Tucson, Arizona, December 3-5, 2006. More information is available at the PDS website.

PRWeb eBooks - Another online visibility tool from PRWeb

###

If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer appears here. - PRWeb eBooks - Another online visibility tool from PRWeb

Contact Information
Arthur C. Karakos Pathology Data Solutions Inc. http://www.PDS-America.com 570-420-0720
Online Web 2.0 Version

If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer appears here. - PRWeb eBooks - Another online visibility tool from PRWeb

CDISC RSP © 2017 PDS. All rights reserved.  Site Map  |  Disclaimer  |  Terms of Use Connect with us on  pds linkedin